Nathalie I. Bouwer
Dordrecht, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk of cancer after ST-segment-elevation myocardial infarction.
Journal: European journal of epidemiology
Published: September 07, 2022
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Journal: International journal of cancer
Published: September 16, 2021
2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab.
Journal: Cardiovascular ultrasound
Published: April 10, 2021
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
Journal: Breast cancer research and treatment
Published: September 14, 2020
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.
Journal: British journal of haematology
Published: July 12, 2020
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice.
Journal: Breast (Edinburgh, Scotland)
Published: October 11, 2019
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Journal: Breast cancer research and treatment
Published: August 20, 2019
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab.
Journal: Cardio-oncology (London, England)
Published: February 15, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026